Valsartan improves mitochondrial function in hearts submitted to acute ischemia

European Journal of Pharmacology

Volumn 518, Issue 2-3, 2005, Pages 158-164

  Monteiro, Pedro ^a   Duarte, Ana I ^b   Gonçalves, Lino M ^a,c   Providência, Luís A ^a,c  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cardioprotection; Cell biology; Heart; Ischemia; Mitochondria; Valsartan

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ASCORBIC ACID; DIAMINE DERIVATIVE; GLUTAMIC ACID; MALIC ACID; SUCCINIC ACID; TETRAPHENYLPHOSPHONIUM; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTRIC POTENTIAL; ELECTRODE; ENERGY YIELD; HEART MUSCLE ISCHEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; PARAMETER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RESPIRATORY CHAIN;

ACUTE DISEASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; HEART; INTRACELLULAR MEMBRANES; MEMBRANE POTENTIALS; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; TETRAZOLES; TIME FACTORS; VALINE;

EID: 23644446746     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.06.013     Document Type: Article

References (28)

1. J.H. Bauer, and G.P. Reams The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs Arch. Intern. Med. 155 1995 1361 1368
2. J.N. Cohn for the Valsartan Heart Failure Trial Investigators A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N. Engl. J. Med. 345 2001 1667 1675
3. G.G. Corbucci Adaptive changes in response to acute hypoxia, ischemia and reperfusion in human cardiac cell Minerva Anestesiol. 66 2000 523 530
4. 1-receptor subtype Br. J. Pharmacol. 110 1993 761 771
5. S. der Sarkissian, E.L. Marchand, D. Duguay, P. Hamet, and D. deBlois Reversal of interstitial fibrobalsat hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril Cardiovasc. Res. 57 2003 775 783
6. A.G. Gornall, C.J. Bardawill, and M.M. David Determination of serum proteins by means of biuret reaction J. Biol. Chem. 177 1949 751 766
7. S. Hein, A. Elsasser, S. Kostin, R. Zimmermann, and J. Schaper Functional disturbances due to structural remodeling in the failing human heart Arch. Mal. Coeur Vaiss. 95 2002 815 820
8. N. Kamo, M. Muratsugu, R. Hongoh, and Y. Kobatake Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state J. Membr. Biol. 49 1979 105 121
9. S. Kim, M. Yoshiyama, Y. Izumi, H. Kawano, M. Kimoto, Y. Zhan, and H. Iwao Effects of combination of ACE inhibition and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure Circulation 103 2001 148 154
10. A. Kuno, T. Miura, A. Tsuchida, T. Hasegawa, T. Miki, Y. Nishino, and K. Shimamoto Blockade of angiotensin II type 1 receptors suppressed free radical production and preserved coronary endothelial function in the rabbit heart after myocardial infarction J. Cardiovasc. Pharmacol. 39 2002 49 57
11. Y.H. Liu, J. Xu, X.P. Yang, F. Yang, E. Shesely, and O.A. Carretero Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure Hypertension 39 2002 375 381
12. J. Marin-Garcia, and M.J. Goldenthal The mitochondrial organelle and the heart Rev. Esp. Cardiol. 55 2002 1293 1310
13. P. Monteiro, A.I. Duarte, A. Moreno, L.M. Gonçalves, and L.A. Providência Carvedilol improves energy production during acute global myocardial ischemia Eur. J. Pharmacol. 482 2003 245 253
14. P. Monteiro, A.I. Duarte, L.M. Gonçalves, A. Moreno, and L.A. Providência Protective effect of trimetazidine on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia Eur. J. Pharmacol. 503 2004 123 128
15. 1 receptor blockade or combined inhibition in congestive heart failure? J. Cardiovasc. Pharmacol. Ther. 6 2001 369 376
16. M.M. Multani, R.S. Krombach, J.W. Hendrick, S.C. Baicu, C. Joffs, J.A. Sample, M. deGasparo, and F.G. Spinale Long-term angiotensin converting enzyme and angiotensin I-receptor inhibition in pacing-induced heart failure: effects on myocardial interstitial bradykinin levels J. Card. Fail. 7 2001 348 354
17. M. Muratsugu, N. Kamo, K. Kurihara, and Y. Kobatabe Selective electrode for dibenzyl dimethyl ammonium cation as indicator of the membrane potential in electrical systems Biochim. Biophys. Acta 464 1977 613 619
18. National Research Council Guide for the Care and Use of Laboratory Animals 1996 National Academy Press Washington, D.C.
19. P.J. Oliveira, T. Esteves, A.P. Rolo, P. Monteiro, L. Gonçalves, C.M. Palmeira, and A.J. Moreno Carvedilol: relation between antioxidant activity and inhibition of the mitochondrial permeability transition Rev. Port. Cardiol. 22 2003 55 62
20. P. Palatini for the Italian Collaborative Study Group A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension J. Hypertens. 19 2001 1691 1696
21. M.A. Pfeffer for the Valsartan in Acute Myocardial Infarction Trial Investigators Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N. Engl. J. Med. 349 2003 1893 1906
22. M.A. Pfeffer On behalf of the Valsartan in Acute Myocardial Infarction Trial Investigators Valsartan, captopril or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N. Engl. J. Med. 349 2003 1893 1906
23. C. Richer, P. Fornes, V. Domergue, M. de Gasparo, and J.F. Giudicelli Combined angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on survival and cardiac remodeling in chronic heart failure in rats J. Card. Fail. 7 2001 269 276
24. D. Rickwood, M.T. Wilson, and V.M. Darley-Usmar Isolation and characteristics of intact mitochondria-isolation of mitochondria from mammalian cells V.M. Darley-Usmar D. Rickwood M.T. Wilson Mitochondria: A Practical Approach 1987 IRL Press Oxford, England 4 5
25. D. Rickwood, M.T. Wilson, and V.M. Darley-Usmar Isolation and characteristics of intact mitochondria-isolation of mitochondria from mammalian cells V.M. Darley-Usmar D. Rickwood M.T. Wilson Mitochondria: A Practical Approach 1987 IRL Press Oxford, England 11 13
26. V. Stocchi, L. Cucchiarini, M. Magnani, L. Chiarantini, P. Palma, and G. Crescentini Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells Anal. Biochem. 146 1985 118 124
27. K. Ylitalo, A. Ala-Rami, K. Vuorinen, K. Peuhkurinen, M. Lepojarvi, and P. Kaukoranta Reversible ischemic inhibition of F(1)F(0)-ATPase in rat and human myocardium Biochim. Biophys. Acta 1504 2001 329 339
28. C.M. Yu, G.L. Tipoe, L.K. Wing-Hon, and C.P. Lau Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction J. Am. Coll. Cardiol. 38 2001 1207 1215